Search research articles
Contact Us
Filters
Showing results (481-490 of 692) with videos related to
Page
of 70
Sort By:
The Journal of Urology
|
January 12, 2022
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide
Alexander Pan, Rachel E Reingold, Jimmy L Zhao, et al.
EJNMMI Research
|
May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
Neeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.
Journal of Immunotherapy and Precision Oncology
|
December 25, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer
Daniel Vargas P de Almeida, Justine M Anderson, Daniel C Danila, et al.
Blood
|
February 3, 1998
Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer
C I Rivas, J C Vera, F Delgado-López, et al.
European Urology Oncology
|
June 18, 2019
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Sungmin Woo, Chong Hyun Suh, James A Eastham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2005
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
Zohar A Dotan, Fernando J Bianco, Farhang Rabbani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts
D Lorente, D Olmos, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2012
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy
C N Sternberg, A Molina, S North, et al.
The Lancet. Oncology
|
October 13, 2012
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study
Robert W Ross, Matthew D Galsky, Howard I Scher, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 10, 2010
Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS
Ann I Scher, Yuan Xu, Esther S C Korf, et al.
Page
of 70
Search research articles
Search
Showing results (481-490 of 692) with videos related to
Sort By:
Page
of 70
The Journal of Urology
|
January 12, 2022
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide
Alexander Pan, Rachel E Reingold, Jimmy L Zhao, et al.
EJNMMI Research
|
May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
Neeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.
Journal of Immunotherapy and Precision Oncology
|
December 25, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer
Daniel Vargas P de Almeida, Justine M Anderson, Daniel C Danila, et al.
Blood
|
February 3, 1998
Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer
C I Rivas, J C Vera, F Delgado-López, et al.
European Urology Oncology
|
June 18, 2019
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Sungmin Woo, Chong Hyun Suh, James A Eastham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2005
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
Zohar A Dotan, Fernando J Bianco, Farhang Rabbani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts
D Lorente, D Olmos, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2012
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy
C N Sternberg, A Molina, S North, et al.
The Lancet. Oncology
|
October 13, 2012
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study
Robert W Ross, Matthew D Galsky, Howard I Scher, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 10, 2010
Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS
Ann I Scher, Yuan Xu, Esther S C Korf, et al.
Page
of 70